These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 20305479)

  • 1. Forcing tumor stem cells to an end.
    Hofstetter CP; Boockvar JA
    Neurosurgery; 2010 Apr; 66(4):N17-8. PubMed ID: 20305479
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy resistance of glioblastoma stem cells.
    Eramo A; Ricci-Vitiani L; Zeuner A; Pallini R; Lotti F; Sette G; Pilozzi E; Larocca LM; Peschle C; De Maria R
    Cell Death Differ; 2006 Jul; 13(7):1238-41. PubMed ID: 16456578
    [No Abstract]   [Full Text] [Related]  

  • 3. A neurosurgeon's guide to stem cells, cancer stem cells, and brain tumor stem cells.
    Cheshier SH; Kalani MY; Lim M; Ailles L; Huhn SL; Weissman IL
    Neurosurgery; 2009 Aug; 65(2):237-49; discussion 249-50; quiz N6. PubMed ID: 19625901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal differentiation of glioblastoma stem cells.
    Ricci-Vitiani L; Pallini R; Larocca LM; Lombardi DG; Signore M; Pierconti F; Petrucci G; Montano N; Maira G; De Maria R
    Cell Death Differ; 2008 Sep; 15(9):1491-8. PubMed ID: 18497759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive view of tumor stem cells and their regulation by the microenvironment in glioblastoma.
    Schiffer D; Annovazzi L; Mellai M
    Neurol Sci; 2017 Mar; 38(3):527-529. PubMed ID: 27853910
    [No Abstract]   [Full Text] [Related]  

  • 6. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.
    Gangemi RM; Griffero F; Marubbi D; Perera M; Capra MC; Malatesta P; Ravetti GL; Zona GL; Daga A; Corte G
    Stem Cells; 2009 Jan; 27(1):40-8. PubMed ID: 18948646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells.
    Oka N; Soeda A; Inagaki A; Onodera M; Maruyama H; Hara A; Kunisada T; Mori H; Iwama T
    Biochem Biophys Res Commun; 2007 Aug; 360(3):553-9. PubMed ID: 17618600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine factors sustain glioblastoma stem cell self-renewal.
    Li G; Chen Z; Hu YD; Wei H; Li D; Ji H; Wang DL
    Oncol Rep; 2009 Feb; 21(2):419-24. PubMed ID: 19148517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoplastic stem cells: a novel therapeutic target in clinical oncology.
    Schulenburg A; Ulrich-Pur H; Thurnher D; Erovic B; Florian S; Sperr WR; Kalhs P; Marian B; Wrba F; Zielinski CC; Valent P
    Cancer; 2006 Nov; 107(10):2512-20. PubMed ID: 17039500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cells recognize and kill human glioblastoma cells with stem cell-like properties.
    Castriconi R; Daga A; Dondero A; Zona G; Poliani PL; Melotti A; Griffero F; Marubbi D; Spaziante R; Bellora F; Moretta L; Moretta A; Corte G; Bottino C
    J Immunol; 2009 Mar; 182(6):3530-9. PubMed ID: 19265131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain tumor stem cells as research and treatment targets.
    Hide T; Takezaki T; Nakamura H; Kuratsu J; Kondo T
    Brain Tumor Pathol; 2008; 25(2):67-72. PubMed ID: 18987831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.
    Shiras A; Chettiar ST; Shepal V; Rajendran G; Prasad GR; Shastry P
    Stem Cells; 2007 Jun; 25(6):1478-89. PubMed ID: 17332509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms that mediate stem cell self-renewal and differentiation.
    Zhang H; Wang ZZ
    J Cell Biochem; 2008 Feb; 103(3):709-18. PubMed ID: 17647265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells in radiation resistance.
    Rich JN
    Cancer Res; 2007 Oct; 67(19):8980-4. PubMed ID: 17908997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of anti-apoptotic and multi-drug resistance-associated protein genes in cancer stem cell isolated from TJ905 glioblastoma multiforme cell line].
    Jin F; Li HS; Zhao L; Wei YJ; Zhang H; Guo YJ; Pang R; Jiang XB; Zhao HY
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2312-6. PubMed ID: 19087689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of cancer stem-like cells from a side population of a human glioblastoma cell line, SK-MG-1.
    Fukaya R; Ohta S; Yamaguchi M; Fujii H; Kawakami Y; Kawase T; Toda M
    Cancer Lett; 2010 May; 291(2):150-7. PubMed ID: 19913993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha.
    Seidel S; Garvalov BK; Wirta V; von Stechow L; Schänzer A; Meletis K; Wolter M; Sommerlad D; Henze AT; Nistér M; Reifenberger G; Lundeberg J; Frisén J; Acker T
    Brain; 2010 Apr; 133(Pt 4):983-95. PubMed ID: 20375133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.
    Günther HS; Schmidt NO; Phillips HS; Kemming D; Kharbanda S; Soriano R; Modrusan Z; Meissner H; Westphal M; Lamszus K
    Oncogene; 2008 May; 27(20):2897-909. PubMed ID: 18037961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide as a potential novel addition to the anti-uremic pruritus weaponry.
    Namazi MR; Fallahzadeh MK; Roozbeh J
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):291-2. PubMed ID: 19237824
    [No Abstract]   [Full Text] [Related]  

  • 20. Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins.
    Tagscherer KE; Fassl A; Campos B; Farhadi M; Kraemer A; Böck BC; Macher-Goeppinger S; Radlwimmer B; Wiestler OD; Herold-Mende C; Roth W
    Oncogene; 2008 Nov; 27(52):6646-56. PubMed ID: 18663354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.